Search
Add Trial
Sign In

An Investigational Immuno-therapy Study of Nivolumab or Placebo in Patients With Resected Esophageal or Gastroesophageal Junction Cancer (CheckMate 577) - Hosted By

0
Study Type Treatment
Sponsor Name BMS
Disease type Gastric Cancer
Disease Stage Esophageal or Gastroesophageal Junction Cancer
Clinical Status Advanced Disease 2nd/3rd line
Phase Phase III
Intervention / Treatment Treatment
Research Site MUHC – McGill University Health Centre
Investigator
Coordinator
Telephone number
Fax number
Study start date
Study end date
Trial Status

Listing Features

Tags

Add Reviews & Rate

Your email is safe with us.

Working Hours :

Now Opening UTC - 4
  • Monday08:00 - 22:00
  • Tuesday08:00 - 22:00
  • Wednesday08:00 - 22:00
  • Thursday08:00 - 22:00
  • Friday08:00 - 22:00
  • Saturday08:00 - 12:00
  • SundayDay Off

Price / Claim :

Recruit a patient:

*for confidentiality, do not include the name of the patient

*pour raisons de confidentialité, n'incluez pas le nom du patient

Hosted by :

Claim listing: An Investigational Immuno-therapy Study of Nivolumab or Placebo in Patients With Resected Esophageal or Gastroesophageal Junction Cancer (CheckMate 577)

Our website is under development. We're sorry for any inconvenience that might appear.Notre site web est en cours de développement. Nous sommes désolés pour tout inconvénient qui pourrait survenir.

Reply to Message

Sign In KANCEL

Account details will be confirmed via email.

Reset Your Password